Role of prostaglandins in hypertension

Journal of Human Hypertension

Volumn 14, Issue , 2000, Pages S16-S19

  Colina Chourio, José A ^a   Godoy Godoy, N ^a   Avila Hernandez R M ^a  

^a UNIVERSIDAD DEL ZULIA   (Venezuela)

Author keywords

Hypertension; Prostaglandins

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; AUTACOID; BRADYKININ; CALCIUM CHANNEL BLOCKING AGENT; CYCLOOXYGENASE 2 INHIBITOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTACYCLIN; PROSTAGLANDIN; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; SULINDAC; THROMBOXANE;

ANTIHYPERTENSIVE ACTIVITY; CLINICAL TRIAL; CONFERENCE PAPER; DRUG MECHANISM; DRUG METABOLISM; DYSLIPIDEMIA; ESSENTIAL HYPERTENSION; HUMAN; NONHUMAN; PEPTIC ULCER; PERIPHERAL VASCULAR DISEASE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ANIMALS; AUTACOIDS; BIOLOGICAL MARKERS; BLOOD PRESSURE; ENDOTHELIUM, VASCULAR; HUMANS; HYPERTENSION; MUSCLE, SMOOTH, VASCULAR; PROSTAGLANDINS; RECEPTORS, PROSTAGLANDIN; VASOCONSTRICTION;

EID: 0034121705     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/sj.jhh.1000981     Document Type: Article

References (45)

1. Campbell WB, Haluska PV. Lipid-derived autacoids. Eicosanoids and platelet-activating factors. In: Hardman JG, Molinoff PB, Ruddon RW, Gilman AG (eds). Goodman & Gilman's The Pharmacological basis of therapeutics. 9th edition, Chapter 26. McGraw-Hill: New York, 1996, pp 601-616.
2. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature 1971; 231: 232-236.
3. de Leeuw PW. Nonsteroidal anti-inflammatory drugs and hypertension. The risks in perspective. Drugs 1996; 51: 179-187.
4. Dyeberg J, Bang HO. Haemostatic function and platelet polyunsaturated fatty acids in Eskimos. Lancet 1979; 2: 433-436.
5. Jorgensen KA, Nielsen AH, Dyeberg J. Hemostatic factors and renin in Greenland Eskimos in a high eicosap-entanoic acid intake. Acta Med Scand 1986; 216: 473-479.
6. Japelli G, Matozzi-Scaffa G. Sur les effects des injection intraveineuses de l'extrait prostatique de chien. Arch Ital Biol 1906; 45: 165-182.
7. Battez G, Boulet L. Action de l'extrait de Prostate humaine sur la vessie et sur la pression arterielle. Comp Rend Soc Biol (Paris) 1913; 74: 8-9.
8. Abelous JE, Bardier E. Les substances hypotensives de l'urine humaine normale. Comp Rend Soc Biol (Paris) 1909; 66: 511-512.
9. Colina-Chourio JA, Oliveros-Palacios MCh, Godoy N, Rodriguez-Iturbe B. Los Sistemas Calicreinas-Cinina y Prostaglandina renales en la hipertensionn arterial. Rev Acad Med Zulia 1988; 21: 8-34.
10. Zusman RM et al. Antihypertensive function of a renal-cell carcinoma. Evidence for a prostaglandins-A-secreting tumor. N Engl J Med 1974; 290: 843-845.
11. Robertson RP, Baylink DJ, Marini BJ, Adkinson HW. Elevated prostaglandins and suppressed parathyroid hormone associated with hypercalcemia and renal cell carcinoma. J Clin Endocrinol Metab 1975; 41: 164-167.
12. Yoshida H, Ura N, Shimamoto K. Prostaglandin and kallikrein-kinin system. Nippon Rinsho 1997; 55: 1909-1914.
13. Arias-Sánchez O et al. El Nobel. Historia, análisis, gal-ardonados. Editorial Voluntad S.A: Bogota (Colombia), 1992, pp 126-127.
14. McGiff JC et al. Selective passage of prostaglandins across the lung. Nature 1969; 35: 2382-2387.
15. Bader J-P (ed). Advances in prostaglandins and gastroenterology: focus on misoprostol. A symposium. Am J Med 1987; 83: 1-52.
16. Cervoni P, Chan PS, Lai FM, Birnaum JE. CL-115, 347 (DHV-PGE2-ME): a new orally and topically active Prostaglandin antihypertensive agent. Fed Proc 1983; 42: 157-161.
17. Guazzi MD et al. Antihypertensive efficacy of angiotensin converting enzyme inhibition and aspirin counteraction. Clin Pharmacol Ther 1998; 63: 79-86.
18. McGiff JC. Bartter's Syndrome results from an imbalance of vasoactive hormones. Ann Int Med 1977; 87: 369-372.
19. Colina-Chourio J, Godoy N, Oliveros-Palacios M, Aro-cha I: Long-term (3 years) sustained antihypertensive and metabolic actions of nitrendipine in severe complicated and resistant hypertension. J Cardiovasc Pharmacol 1991; 18 (1): 84-90.
20. González JD et al. Role of nitric oxide and prostaglandins in the long-term control of renal function. Hypertension 1998; 32: 33-38.
21. Ortíz MC et al. Importance of nitric oxide and prostaglandins in the control of rat renal papillary blood flow. Hypertension 1996; 27: 377-381.
22. Siragy HM, Jaffa AA, Margolius HS. Bradykinin B2 receptor modulates renal prostaglandin E2 and nitric oxide. Hypertension 1997; 29: 757-762.
23. Goodfriend TL, Egan BM. Nonesterified fatty acids in the pathogenesis of hypertension: Theory and evidence. Prostag Leuk Essent Fatty Acids 1997; 57: 57-63.
24. Lärsson C. Arachidonic acid lowers and Indomethacin increases the blood pressure of the rabbit. Br J Pharmacol 1973; 25: 653-655.
25. Nasjletti A et al. High potassium intake selectively increases urinary PGF2q, excretion in the rat. Am J Physiol 1985; 248: F382-F388.
26. Colina-Chourio J, McGiff JC, Miller MP, Nasjletti A. Possible influence of intrarenal generation of kinins on prostaglandin release from the rabbit perfused kidney. Br J Pharmacol 1976; 58: 165-172.
27. Colina-Chourio JA, Rodriguez-Iturbe B. Usos clinicos de los inhibidores de la Enzima Convertidora. Invest Clin 1984; 25: 33-47.
28. Mullane KM, Moncada S, Vane JR. Prostacyclin release-induced bradykinin may contribute to the antihypertensive action of angiotensin converting enzyme inhibitors. Adv Prost Thromb Res 1980; 7: 1158-1161.
29. Weber PC, Schere B, Lärsson C. Increase of free arachi-donic acid by frusemide in man: the cause of prostaglandin and renin realease. Euro J Pharmacol 1977; 41: 329-333.
30. Ribeiro MO et al. Nifedipine prevents renal injury in rats with chronic nitric oxide inhibition. Hypertension 1995; 26: 150-155.
31. Muñoz-Garcia R et al. Acute renal excretory actions of losartan in sponteneously hypertensive rats: role of AT2 receptors, prostaglandins, kinins and nitric oxide. J Hypertens 1995; 13: 1779-1784.
32. Colina-Chourio JA et al. Urinary excretion of ProstaglandinsPGE2 and PFG2 J and Kallikrein in acute glomerulonephritis. Clin Nephrol 1983; 20: 217-224.
33. Parra G, Rodríguez-Iturbe B, Colina-Chourio J, Garcia R. Short-term treatment with captopril in hypertension due to acute glomerulonephritis. Clin Nephrol 1988; 29: 58-62.
34. LaPointe MC, Sitkins JR. Phospholipase A2 metabolites regulate inducible nitric oxide synthase in myocytes. Hypertension 1998; 31: 218-224.
35. Csukas S, Hanke CJ, Rewolinski D, Campbell WB. Prostaglandin E2-induced aldosterone release is mediated by an EP2 receptor. Hypertension 1998; 31: 575-581.
36. Colina-Chourio J, McGiff JC, Nasjletti A. Effect of indo-methacin on blood pressure in the normotensive unanaesthetized rabbit: possible relation to prostaglandin synthesis inhibition. Clin Sci 1979; 57: 359-365.
37. Bartter FC, Pronove P, Gill JR, MacCardle RC. Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosis. Am J Med 1962; 33: 81.828.
38. Haluska PV et al. Bartter's Syndrome: Urinary prostaglandins E-like material and kallikrein; indomethacin efects. Ann Int Med 1977; 87: 281-286.
39. Slotkof LM. Prostaglandin A1 in hypertensive crisis. Ann Int Med 1967; 81: 345-347.
40. Hoper MM et al. Prostaglandins induce vascular endothelial growth factor in a human monocytic cell line and rat lungs via cAMP. Am J Respir Cell Mol Biol 1997; 17: 748-756.
41. Moncada S, Gryglewski R, Bunting S, Vane JR. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 1976; 263: 663-665.
42. Vural P, Akgül C, Canbaz M. Urinary PGE2 and PGF2a levels and renal function in preeclampsia. Gynecol Obstet Invest 1998; 45: 237-241.
43. Paalberg KM et al. Vasoactive mediators in pregnancy-induced hypertensive disorders: a longitudinal study. Am J Obstet Gynecol 1998; 179: 1559-1564.
44. Arbogast E, Schäfer W, Zahradnik HP. Alterations of intrauterine eicosanoid production in pregnancy-induced hypertension: decreased production of 12-hydroxyeicosatetraenoic acid in the placenta. Prostaglandins 1996; 51: 125-137.
45. Klochenbusch W et al. Thrombocyte prostacyclin receptors in gestational hypertension and pre-eclampsia. Z Geburtshilfe Neonatol 1996; 200: 96-99.